ADPT

Latest SEC Filings & News for ADPT

2 most recent filings and news items mentioning ADPT. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/ADPT/news?limit=20"

Pull ADPT filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Adaptive Biotechnologies issues 0% convertible senior notes due 2031

Adaptive Biotechnologies Corporation entered into an indenture with U.S. Bank Trust Company for 0% convertible senior notes due 2031, dated June 22, 2026. This debt offering provides the company with capital financing while offering investors conversion rights to equity.

View filing at SEC.gov →

Adaptive Biotechnologies proposes $250M convertible senior notes offering due 2031

Adaptive Biotechnologies announced a proposed $250 million convertible senior notes offering to repay OrbiMed obligations and fund stock repurchases. Proceeds will enhance financial flexibility and support general corporate purposes and MRD business initiatives.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.